<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38587211</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts.</ArticleTitle><Pagination><StartPage>e29597</StartPage><MedlinePgn>e29597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29597</ELocationID><Abstract><AbstractText>The Coronavirus Disease 2019 (COVID-19)&#xa0;pandemic has resulted in the loss of millions of lives, although a majority of those infected have managed to survive. Consequently, a set of outcomes, identified as long COVID, is now emerging. While the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the respiratory system, the impact of COVID-19 extends to various body parts, including the bone. This study aims to investigate the effects of acute SARS-CoV-2 infection on osteoclastogenesis, utilizing both ancestral and Omicron viral strains. Monocyte-derived macrophages,&#xa0;which serve as precursors to osteoclasts, were exposed to both viral variants. However, the infection proved abortive, even though ACE2 receptor expression increased postinfection, with no significant impact on cellular viability and redox balance. Both SARS-CoV-2 strains heightened osteoclast formation in a dose-dependent manner, as well as CD51/61 expression and bone resorptive ability. Notably, SARS-CoV-2 induced early pro-inflammatory M1 macrophage polarization, shifting toward&#xa0;an M2-like profile. Osteoclastogenesis-related genes (RANK, NFATc1, DC-STAMP, MMP9) were upregulated, and surprisingly, SARS-CoV-2 variants promoted RANKL-independent osteoclast formation. This thorough investigation illuminates the intricate interplay between SARS-CoV-2 and osteoclast precursors, suggesting potential implications for bone homeostasis and opening new avenues for therapeutic exploration in COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sviercz</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarmoluk</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godoy Coto</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Centro de Investigaciones Cardiovasculares "Dr. Horacio E. Cingolani", Universidad Nacional de la Plata (UNLP), La Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cevallos</LastName><ForeName>Cintia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freiberger</LastName><ForeName>Rosa Nicole</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Cinthya Alicia Marcela</ForeName><Initials>CAM</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ennis</LastName><ForeName>Irene Lucia</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Centro de Investigaciones Cardiovasculares "Dr. Horacio E. Cingolani", Universidad Nacional de la Plata (UNLP), La Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delpino</LastName><ForeName>M Victoria</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quarleri</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5110-8773</Identifier><AffiliationInfo><Affiliation>Consejo de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>PICTO 2021-COVID secuelas-00005 to JQ, and ILE</Agency><Country/></Grant><Grant><Agency>Agencia Nacional de Promoci&#xf3;n Cient&#xed;fica y Tecnol&#xf3;gica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010010" MajorTopicYN="Y">Osteoclasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">RANKL</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">bone</Keyword><Keyword MajorTopicYN="N">monocyte&#x2010;derived macrophages</Keyword><Keyword MajorTopicYN="N">osteoclasts</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>7</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38587211</ArticleId><ArticleId IdType="doi">10.1002/jmv.29597</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID&#x2010;19. Nat Med. 2020;26(7):1017&#x2010;1032.</Citation></Reference><Reference><Citation>Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person&#x2010;to&#x2010;person transmission: a study of a family cluster. Lancet. 2020;395(10223):514&#x2010;523.</Citation></Reference><Reference><Citation>To KKW, Sridhar S, Chiu KHY, et al. Lessons learned 1 year after SARS&#x2010;CoV&#x2010;2 emergence leading to COVID&#x2010;19 pandemic. Emerg Microbes Infect. 2021;10(1):507&#x2010;535.</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against C&#x2010;P&#x2010;ACSG. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. Retracted: 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631.</Citation></Reference><Reference><Citation>Maffia&#x2010;Bizzozero S, Cevallos C, Lenicov FR, et al. Viable SARS&#x2010;CoV&#x2010;2 Omicron sub&#x2010;variants isolated from autopsy tissues. Front Microbiol. 2023;14:1192832.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation></Reference><Reference><Citation>Kottlors J, Gro&#xdf;e Hokamp N, Fervers P, et al. Early extrapulmonary prognostic features in chest computed tomography in COVID&#x2010;19 pneumonia: bone mineral density is a relevant predictor for the clinical outcome &#x2013; a&#xa0;multicenter feasibility study. Bone. 2021;144:115790.</Citation></Reference><Reference><Citation>Sapra L, Saini C, Garg B, et al. Long&#x2010;term implications of COVID&#x2010;19 on bone health: pathophysiology and therapeutics. Inflamm Res. 2022;71(9):1025&#x2010;1040.</Citation></Reference><Reference><Citation>Harris A, Creecy A, Awosanya OD, et al. SARS&#x2010;CoV&#x2010;2 and its multifaceted impact on bone health: mechanisms and clinical evidence. Curr Osteoporos Rep. 2024;22:135&#x2010;145.</Citation></Reference><Reference><Citation>Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of C&#x2010;Fms and receptor activator of nuclear factor &#x3ba;b (Rank) receptors. J Exp Med. 1999;190(12):1741&#x2010;1754.</Citation></Reference><Reference><Citation>Jacome&#x2010;Galarza CE, Percin GI, Muller JT, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019;568(7753):541&#x2010;545.</Citation></Reference><Reference><Citation>Shibakawa A, Yudoh K, Masuko&#x2010;Hongo K, Kato T, Nishioka K, Nakamura H. The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrow. Osteoarthritis Cartilage. 2005;13(8):679&#x2010;687.</Citation></Reference><Reference><Citation>Raynaud&#x2010;Messina B, Bracq L, Dupont M, et al. Bone degradation machinery of osteoclasts: an HIV&#x2010;1 target that contributes to bone loss. Proc Natl Acad Sci U S A. 2018;115(11):E2556&#x2010;E2565.</Citation></Reference><Reference><Citation>Sviercz FA, Jarmoluk P, Cevallos CG, et al. Massively HIV&#x2010;1&#x2010;infected macrophages exhibit a severely hampered ability to differentiate into osteoclasts. Front Immunol. 2023;14:1206099.</Citation></Reference><Reference><Citation>Mumtaz N, Koedam M, van Leeuwen JPTM, Koopmans MPG, van der Eerden BCJ, Rockx B. Zika virus infects human osteoclasts and blocks differentiation and bone resorption. Emerg Microbes Infect. 2022;11(1):1621&#x2010;1634.</Citation></Reference><Reference><Citation>Qiao W, Lau HE, Xie H, et al. SARS&#x2010;CoV&#x2010;2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun. 2022;13(1):2539.</Citation></Reference><Reference><Citation>Awosanya OD, Dalloul CE, Blosser RJ, et al. Osteoclast&#x2010;mediated bone loss observed in a COVID&#x2010;19 mouse model. Bone. 2022;154:116227.</Citation></Reference><Reference><Citation>Gao J, Mei H, Sun J, et al. Neuropilin&#x2010;1&#x2010;mediated SARS&#x2010;CoV&#x2010;2 infection in bone marrow&#x2010;derived macrophages inhibits osteoclast differentiation. Adv Biol. 2022;6(5):e2200007.</Citation></Reference><Reference><Citation>Schmittgen TD, Livak KJ. Analyzing real&#x2010;time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101&#x2010;1108.</Citation></Reference><Reference><Citation>Zheng J, Wang Y, Li K, Meyerholz DK, Allamargot C, Perlman S. Severe acute respiratory syndrome coronavirus 2&#x2010;induced immune activation and death of monocyte&#x2010;derived human macrophages and dendritic cells. J Infect Dis. 2021;223(5):785&#x2010;795.</Citation></Reference><Reference><Citation>Choi HK, Kim TH, Jhon GJ, Lee SY. Reactive oxygen species regulate M&#x2010;CSF&#x2010;induced monocyte/macrophage proliferation through SHP1 oxidation. Cell Signal. 2011;23(10):1633&#x2010;1639.</Citation></Reference><Reference><Citation>Haudenschild AK, Christiansen BA, Orr S, et al. Acute bone loss following SARS&#x2010;CoV&#x2010;2 infection in mice. J Orthop Res. 2023;41(9):1945&#x2010;1952.</Citation></Reference><Reference><Citation>Queiroz&#x2010;Junior CM, Santos ACPM, Gon&#xe7;alves MR, et al. Acute coronavirus infection triggers a TNF&#x2010;dependent osteoporotic phenotype in mice. Life Sci. 2023;324:121750.</Citation></Reference><Reference><Citation>Yang C, Ma X, Wu J, et al. Low serum calcium and phosphorus and their clinical performance in detecting COVID&#x2010;19 patients. J Med Virol. 2021;93(3):1639&#x2010;1651.</Citation></Reference><Reference><Citation>di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID&#x2010;19: prevalence, clinical significance and therapeutic implications. Rev Endocr Metab&#xa0;Disord. 2022;23(2):299&#x2010;308.</Citation></Reference><Reference><Citation>Buccino F, Zagra L, Longo E, et al. Osteoporosis and Covid&#x2010;19: detected similarities in bone lacunar&#x2010;level alterations via combined AI and advanced synchrotron testing. Mater Des. 2023;231:112087.</Citation></Reference><Reference><Citation>Thorne LG, Reuschl AK, Zuliani&#x2010;Alvarez L, et al. SARS&#x2010;CoV&#x2010;2 sensing by RIG&#x2010;I and MDA5 links epithelial infection to macrophage inflammation. EMBO J. 2021;40(15):e107826.</Citation></Reference><Reference><Citation>Abdelmoaty MM, Yeapuri P, Machhi J, et al. Defining the innate immune responses for SARS&#x2010;CoV&#x2010;2&#x2010;human macrophage interactions. Front Immunol. 2021;12:741502.</Citation></Reference><Reference><Citation>Dalskov L, M&#xf8;hlenberg M, Thyrsted J, et al. SARS&#x2010;CoV&#x2010;2 evades immune detection in alveolar macrophages. EMBO Rep. 2020;21(12):e51252.</Citation></Reference><Reference><Citation>Labzin LI, Chew KY, Eschke K, et al. Macrophage ACE2 is necessary for SARS&#x2010;CoV&#x2010;2 replication and subsequent cytokine responses that restrict continued virion release. Sci Signal. 2023;16(782):eabq1366.</Citation></Reference><Reference><Citation>Niles MA, Gogesch P, Kronhart S, et al. Macrophages and dendritic cells are not the major source of pro&#x2010;inflammatory cytokines upon SARS&#x2010;CoV&#x2010;2 infection. Front Immunol. 2021;12:647824.</Citation></Reference><Reference><Citation>Evans BJ, Haskard DO, Sempowksi G, Landis RC. Evolution of the macrophage CD163 phenotype and cytokine profiles in a human model of resolving inflammation. Int J Inflammation. 2013;2013:780502.</Citation></Reference><Reference><Citation>Sun Y, Li J, Xie X, et al. Macrophage&#x2010;osteoclast associations: origin, polarization, and subgroups. Front Immunol. 2021;12:778078.</Citation></Reference><Reference><Citation>Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787&#x2010;795.</Citation></Reference><Reference><Citation>Davis MJ, Tsang TM, Qiu Y, et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. mBio. 2013;4(3):e00264&#x2010;13.</Citation></Reference><Reference><Citation>Yang J, Park OJ, Kim J, Kwon Y, Yun CH, Han SH. Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential. J Cell Physiol. 2019;234(12):23033&#x2010;23042.</Citation></Reference><Reference><Citation>Cords L, Woost R, Kummer S, et al. Frequency of IRF5+ dendritic cells is associated with the TLR7&#x2010;induced inflammatory cytokine response in SARS&#x2010;CoV&#x2010;2 infection. Cytokine. 2023;162:156109.</Citation></Reference><Reference><Citation>Tan HY, Wang N, Li S, Hong M, Wang X, Feng Y. The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases. Oxid Med Cell Longevity. 2016;2016:2795090.</Citation></Reference><Reference><Citation>Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu ZG. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor&#x2010;associated macrophages. Cell Res. 2013;23(7):898&#x2010;914.</Citation></Reference><Reference><Citation>Xia Y, Inoue K, Du Y, et al. TGF&#x3b2; reprograms TNF stimulation of macrophages towards a non&#x2010;canonical pathway driving inflammatory osteoclastogenesis. Nat Commun. 2022;13(1):3920.</Citation></Reference><Reference><Citation>Mohammadian Erdi A, Zakavi M, Amani M, Fooladi S, Abedi A. Clinical manifestations of pain in patients suffering from COVID&#x2010;19 infected with Delta variant of SARS&#x2010;Cov&#x2010;2. Front Pain Res. 2023;4:1282527.</Citation></Reference><Reference><Citation>Hoshijima H, Mihara T, Seki H, Hyuga S, Kuratani N, Shiga T. Incidence of long&#x2010;term post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection related to pain and other symptoms: a systematic review and meta&#x2010;analysis. PLoS One. 2023;18(11):e0250909.</Citation></Reference><Reference><Citation>Alexander AJ, Joshi A, Mehendale A. The musculoskeletal manifestations of COVID&#x2010;19: a narrative review article. Cureus. 2022;14(9):e29076.</Citation></Reference><Reference><Citation>di Filippo L, Allora A, Locatelli M, et al. Hypocalcemia in COVID&#x2010;19 is associated with low vitamin D levels and impaired compensatory PTH response. Endocrine. 2021;74(2):219&#x2010;225.</Citation></Reference><Reference><Citation>di Filippo L, Frara S, Giustina A. The emerging osteo&#x2010;metabolic phenotype of COVID&#x2010;19: clinical and pathophysiological aspects. Nat Rev Endocrinol. 2021;17(8):445&#x2010;446.</Citation></Reference><Reference><Citation>Berkta&#x15f; BM, G&#xf6;k&#xe7;ek A, Hoca NT, Koyuncu A. COVID&#x2010;19 illness and treatment decrease bone mineral density of surviving hospitalized patients. Eur Rev Med Pharmacol Sci. 2022;26(8):3046&#x2010;3056.</Citation></Reference><Reference><Citation>Kerschan&#x2010;Schindl K, Dovjak P, Butylina M, et al. Moderate COVID&#x2010;19 disease is associated with reduced bone turnover. J Bone Miner Res. 2023;38(7):943&#x2010;950.</Citation></Reference><Reference><Citation>Battisti S, Napoli N, Pedone C, et al. Vertebral fractures and mortality risk in hospitalised patients during the COVID&#x2010;19 pandemic emergency. Endocrine. 2021;74(3):461&#x2010;469.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>